We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300085:SZSEShenzhen Infogem Technologies Co., Ltd. Class A Analysis

Data as of 2026-06-13 - not real-time

CN¥26.65

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Shenzhen InfoGem Technologies is trading well below its short‑term and medium‑term moving averages, signaling a bearish technical backdrop. The relative strength index sits in oversold territory, yet the momentum remains negative as the MACD line trails its signal line. Valuation metrics are dramatically stretched, with price‑to‑earnings and price‑to‑book ratios far exceeding industry norms, suggesting the market is pricing in unrealistic expectations. Fundamental performance is weak, marked by negative operating margins and a loss per share, while cash balances are roughly matched by debt, limiting financial flexibility. Volume has been rising, providing decent liquidity, but price volatility remains exceptionally high, reflecting heightened market uncertainty. The technology sector in China faces heightened regulatory scrutiny, adding an extra layer of risk. Geographic exposure across multiple developed markets offers diversification but also introduces currency and geopolitical considerations. Overall, the stock appears overvalued relative to its earnings outlook and carries a blend of technical weakness and fundamental challenges. Investors should be cautious, focusing on risk management and monitoring any signs of operational improvement. A prudent approach would be to avoid new positions until clearer upside catalysts emerge.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price below short‑term moving averages
  • bearish MACD divergence
  • extremely stretched valuation multiples

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • increasing trading volume providing liquidity
  • potential for operational turnaround
  • persistent negative earnings and high debt

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • exposure to diversified international markets
  • ongoing regulatory environment in China
  • uncertain path to profitability

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
Profit Margin-16.71%
P/E Ratio266.5
ROE-29.02%
Debt/Equity61.48
P/B Ratio44.9
Op. Cash FlowCN¥42.7M
Industry P/E36.8

Technical Analysis

TrendBearish
RSI31.3
SupportCN¥24.45
ResistanceCN¥44.62
MA 20CN¥35.64
MA 50CN¥37.10
MA 200CN¥42.52
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥0.78
GradeOvervalued
TypeValue

Risk Assessment

Beta0.75
Volatility89.02%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.